- Home
- Issues
- Tuberculosis
- COVID-19
- HIV/AIDS
- Hepatitis
- Non-communicable diseases (NCDs)
- Diabetes
- Cancer
- Asthma
- End tobacco
- Anti-microbial resistance
- Health security
- Gender justice
- Climate justice
- Development justice
- Pneumonia
- Malaria
- Sustainable energy
- Nuclear disarmament
- Corporate accountability
- Advocacy and campaigning Days
- Correspondents
- Publications
- Online communications
- Conference coverage
- GAMA
- सीएनएस
- About
Gender equality and human rights are indivisible, foundational and unconditional
"When human rights are treated like an 'à la carte menu' by governments, and not what they truly are - indivisible, foundational and unconditional... we move fast into dystopia," said Dr Tlaleng Mofokeng, United Nations (UN) Special Rapporteur on Right To Health.
Finding strength in struggle for gender equality and human rights
The year 2025 marks 30 years since the landmark Beijing Declaration and its Platform for Action was adopted in 1995. Despite rising anti-rights and anti-gender pushes, some progress on these bold promises gives hope and strength, to strive for achieving SDG5 fully by 2030 or earlier.
Design health services around people, not the disease
"We need to design services around people, not the disease," rightly said Dr Nittaya Phanuphak. Unless point-of-care health technologies are deployed for those who are most-in-need in a person-centred and rights-based manner, we would fail to deliver on the promises enshrined in #HealthForAll and SDGs goals and targets.
Legalising key population led health services in Thailand is a gamechanger
Legalising key population or community-led health services has been a gamechanger in Thailand to protect most-at-risk people from getting infected with HIV, as well as to take evidence-based standard care to the people living with HIV in a person-centred manner so that they can lead normal healthy lives, said Dr Praphan Phanuphak, a legend who helped shape Thailand's HIV response since the first few AIDS cases got diagnosed in the land of smiles in 1985.
To be or not to be? Daily oral versus long-acting injectable medicines for HIV prevention
Scientific research has gifted us with a range of evidence-based options to protect ourselves from getting infected with HIV. In 2012, US FDA had first approved Pre-Exposure Prophylaxis (PrEP) daily oral medicines for HIV prevention. More recently, long-acting injectable options of PrEP are also approved. We at CNS listened to the experts on both of these PrEP options so that we can make an informed choice.
Include males too in addressing human papilloma virus and related cancers
Human Papilloma Virus (HPV) is a common sexually transmitted infection. Since an effective HPV vaccine exists and HPV screening and treatment of pre-cancer lesions can save lives, no one should be suffering from any of the HPV related cancer or had to die of it.
Will we rise to #endAIDS challenge or stumble withering away the gains in HIV response?
We have all the scientifically proven tools to end AIDS. It is about ensuring that these tools reach people who need them the most, through a sustainable HIV response, so said Dr Adeeba Kamarulzaman, the well known infectious diseases expert form Malaysia and a former President of International AIDS Society (IAS). She was speaking at the plenary of the 10th Asia Pacific AIDS and Co-infections Conference (APACC 2025) in Tokyo, Japan.
Unite Health systems with Community-led health services to deliver on UHC
We cannot deliver on universal health coverage (UHC) unless we reach the unreached people with standard health services – with equity and human dignity. Uniting Health systems with Community-led health services should be the new lens to look at UHC.
We can do better so that all people with HIV live healthy normal lifespans
Love oneself. Stay healthy. And have a health-seeking behaviour to ensure all of us get to age with rights and remain disease-free.
CNS Live with Dr N Kumarasamy on long-acting ARVs for HIV prevention and treatment
![]() |
Register here |
Join us in CNS Live session with Dr N Kumarasamy on 9th June 2025, Monday at 3:30pm IST. He will share latest updates on long-acting antiretroviral therapies for HIV prevention as well as treatment, and insights on preventing and managing advanced HIV disease (AHD).
CNS Live with Dr Nittaya Phanuphak on key population led health services and progress towards ending AIDS by 2030
![]() |
Watch the recording |
Despite being preventable and curable cervical cancer remains 4th biggest cancer in women
Cervical cancer (cancer of the cervix) is preventable and curable, only if it is detected early and managed effectively. Yet it is the 4th most common cancer among women worldwide, with the disease occurring in 660,000 women and claiming the lives of 350,000 women in 2022 worldwide, as per the World Health Organization (WHO).
Subscribe to:
Posts (Atom)